Resource Utilization after First Trimester Noninvasive Fetal RHD Screening for Targeted Antenatal Anti-D Prophylaxis in RhD-Negative Swedish Women

被引:0
|
作者
Neovius, M. [2 ]
Tiblad, E. [1 ,3 ]
Westgren, M. [3 ]
Neovius, K. [2 ]
Wikman, A. T. [1 ,4 ]
机构
[1] Karolinska Univ Hosp, Stockholm, Sweden
[2] Karolinska Inst, Clin Epidemiol Unit, Stockholm, Sweden
[3] Karolinska Inst, Clintec, Stockholm, Sweden
[4] Karolinska Inst, Labmed, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
S4-010A
引用
收藏
页码:18A / 19A
页数:2
相关论文
共 42 条
  • [31] Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS
    Soothill, P. W.
    Finning, K.
    Latham, T.
    Wreford-Bush, T.
    Ford, J.
    Daniels, G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (12) : 1682 - 1686
  • [32] Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?
    Akkok, Cigdem Akalin
    TRANSFUSION AND APHERESIS SCIENCE, 2024, 63 (04)
  • [33] Evaluation of Two Real-Time Multiplex PCR Screening Assays Detecting Fetal RHD in Plasma from RhD Negative Women to Ascertain the Requirement for Antenatal RhD Prophylaxis
    Clausen, Frederik Banch
    Krog, Grethe Risum
    Rieneck, Klaus
    Rasmark, Emma Elin Frida
    Dziegiel, Morten Hanefeld
    FETAL DIAGNOSIS AND THERAPY, 2011, 29 (02) : 155 - 163
  • [34] An audit of cell free fetal DNA (cffDNA) screen to avoid administration of anti-D immunoglobulin in RHD negative pregnant women with RHD negative fetus
    Gurung, K.
    Masters, J.
    Rathod, N.
    Sugai, T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 280 - 281
  • [35] Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands
    de Haas, Masja
    Thurik, Florentine F.
    van der Ploeg, Catharina P. B.
    Veldhuisen, Barbera
    Hirschberg, Hoang
    Soussan, Aicha Ait
    Woortmeijer, Heleen
    Abbink, Frithjofna
    Page-Christiaens, Godelieve C. M. L.
    Scheffer, Peter G.
    van der Schoot, C. Ellen
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
  • [36] Sensitivity of Fetal RhD Screening for Safe Guidance of Targeted Anti-D Immunoglobulin Prophylaxis: Prospective Cohort Study of a Nationwide Programme in the Netherlands
    de Haas, Masja
    Thurik, Florentine F.
    van der Ploeg, Catharina P. B.
    Veldhuisen, Barbera
    Hirschberg, Hoang
    Soussan, Aicha Ait
    Woortmeijer, Heleen
    Abbink, Frithjofna
    Page-Christiaens, Godelieve C. M. L.
    Scheffer, Peter G.
    van der Schoot, C. Ellen
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2017, 72 (03) : 155 - 157
  • [37] Time points and risk factors for RhD immunizations after the implementation of targeted routine antenatal anti-D prophylaxis: A retrospective nationwide cohort study
    Jernman, Riina
    Isaksson, Camilla
    Haimila, Katri
    Kuosmanen, Malla
    Makikallio-Anttila, Kaarin
    Toivonen, Suvi
    Orden, Maija-Riitta
    Sulin, Kati
    Tihtonen, Kati
    Vaarasmaki, Marja
    Sainio, Susanna
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2021, 100 (10) : 1868 - 1875
  • [38] A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales
    Ala Szczepura
    Leeza Osipenko
    Karoline Freeman
    BMC Pregnancy and Childbirth, 11
  • [39] Evaluation of anti-D antibody in RHD-negative pregnant women in emergency county clinical hospital of Oradea, Romania - A Retrospective study
    Muresan, M.
    Daina, L.
    Micle, O.
    Zaha, D. C.
    Teusdea, L.
    Tica, O.
    Tica, O.
    Naghi, P.
    Antal, L.
    CLINICA CHIMICA ACTA, 2019, 493 : S266 - S266
  • [40] A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales
    Szczepura, Ala
    Osipenko, Leeza
    Freeman, Karoline
    BMC PREGNANCY AND CHILDBIRTH, 2011, 11